Inpatient Smoking Cessation Pilot Program

Phase < 1

Waitlist Available

Led By Mandeep S. Jassal, MD, MPH

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial focuses on helping caregivers of hospitalized children quit smoking. Caregivers receive advice about the dangers of smoking around kids and are given nicotine patches or gum to help them stop. The goal is to improve the health of both the children and their caregivers by reducing exposure to harmful smoke. Nicotine patches and gum have been shown to be effective in helping people quit smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Self-reported attempts to quit smoking

Secondary study objectives

Change in Frequency of usage of outpatient tobacco cessation services

Change in Usage of nicotine replacement therapy products

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Cessation interventionExperimental Treatment5 Interventions

All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care. Nicotine replacement therapy: Nicoderm patches, gum, lozenges * Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg) * Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg) * High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg) Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nicotine gum

2015

Completed Phase 4

~2410

Nicotine patch

2015

Completed Phase 4

~6130